•
-
Planetary Health
From Discovery to Field: How Bayer Crop Science R&D Turns Innovation into Solutions for Farmers
Join Bayer Crop Science researchers and innovators for a hybrid presentation and panel discussion exploring how cutting-edge R&D is transforming agricultural innovation. Speakers will cover AI foundation models and multimodal approaches for trait discovery, AI-enabled protein design for herbicide tolerance and insect control, next-generation crop protection strategies for new modes of action, and leveraging open innovation to advance Bayer's biologicals portfolio. The session concludes with a moderated panel discussion on the future of agricultural science and its impact on farmers worldwide.
Featuring
Lyle Ralston
Bayer Crop Science
CE Platform Lead
Engineering Crops for global food security
Leah Briscoe
Bayer Crop Science
Data Scientist
Tommi White
Bayer Crop Science
Structure & Mech. Team Lead
Paramita Deria
Bayer Crop Science
Discovery Chem. & Chem. Biology
Alberto Iandolino
Bayer Crop Science
Ext. Innov. & Partnership - Biologics
Joshua Geilhufe
Rhiza Bio Cons.
Principal
First-market strategist for synbio agriculture and fermentation.
•
-
Planetary Health
From Discovery to Field: How Bayer Crop Science R&D Turns Innovation into Solutions for Farmers
Join Bayer Crop Science researchers and innovators for a hybrid presentation and panel discussion exploring how cutting-edge R&D is transforming agricultural innovation. Speakers will cover AI foundation models and multimodal approaches for trait discovery, AI-enabled protein design for herbicide tolerance and insect control, next-generation crop protection strategies for new modes of action, and leveraging open innovation to advance Bayer's biologicals portfolio. The session concludes with a moderated panel discussion on the future of agricultural science and its impact on farmers worldwide.
Featuring
Lyle Ralston
Bayer Crop Science
CE Platform Lead
Engineering Crops for global food security
Leah Briscoe
Bayer Crop Science
Data Scientist
Tommi White
Bayer Crop Science
Structure & Mech. Team Lead
Paramita Deria
Bayer Crop Science
Discovery Chem. & Chem. Biology
Alberto Iandolino
Bayer Crop Science
Ext. Innov. & Partnership - Biologics
Joshua Geilhufe
Rhiza Bio Cons.
Principal
First-market strategist for synbio agriculture and fermentation.
SynBioBeta is where the people building with biology meet the people funding, buying, and partnering with them. If you're raising capital, scouting the next wave of AIxBIO companies, or looking for your next technology partner - the people you need are here for three days.
The startups on stage this year are building programmable RNA medicines, virtual cell models, AI-designed enzymes, and proteins that replace sugar - alongside GSK, Sanofi, Novo Nordisk, Eli Lilly, J&J, Mars, Apple, Google, NVIDIA, Unilever, and P&G.
Watching where the partnerships form and which technologies the biggest players are actually evaluating is something you can't get from a report or a webinar. And our 1:1 Partnering App lets you book meetings before you arrive.
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
Eric Schmidt
Former CEO
"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."
Celestine Schnugg
Founder
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
Surge Biswas
Founder
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
Jacob Glanville
Founder & CEO
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
Bill Tai
Co-founder
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
Luis Cascao-Pereira
Head of Digital Biology
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
Ola Wlodek
CEO
